During renal fibrogenesis, tubular epithelial-mesenchymal transition is closely associated with peritubular inflammation; however, it is not clear whether these two processes are connected. We previously identified the inhibitor of differentiation-1 (Id1), a dominant negative antagonist of basic helix-loop-helix transcription factors, as a major trigger of tubular cell dedifferentiation after injury. Id1 was induced selectively in degenerated proximal tubule and collecting duct epithelia after injury and was present in both the cytoplasm and nucleus, suggesting shuttling between these two compartments. Interestingly, the upregulation of Id1 was associated with peritubular inflammation in mouse and human nephropathies. In vitro, Id1 potentiated NF-κB signaling and augmented RANTES expression in kidney epithelial cells, which led to an enhanced recruitment of inflammatory cells. Id1 also induced Snail1 expression and triggered tubular epithelial dedifferentiation. In vivo, genetic ablation of Id1 in mice reduced peritubular inflammation and decreased tubular expression of RANTES following ureteral obstruction. Mice lacking Id1 were also protected against myofibroblast activation and matrix expression, leading to a reduced total collagen deposition in obstructive nephropathy. Thus, these results indicate that Id1 shuttles between nucleus and cytoplasm and promotes peritubular inflammation and tubular epithelial dedifferentiation, suggesting that these two events are intrinsically coupled during renal fibrogenesis.
Introduction
Renal tubulointerstitial fibrosis (TIF) is often regarded as the final outcome of a wide range of progressive chronic kidney diseases. The pathogenesis of TIF is characterized by chronic peritubular inflammation, tubular cell dedifferentiation and epithelial-mesenchymal transition (EMT), and myofibroblast activation. [1] [2] [3] [4] These events ultimately lead to an overproduction and excessive deposition of extracellular matrix (ECM), and destruction of the fine architecture of kidney parenchyma. It is generally believed that after a variety of insults, the injured tubular epithelia produce and secrete a host of chemokines, which trigger peritubular infiltration of inflammatory cells. [5] [6] [7] [8] The inflamed milieus, in turn, set up local microenvironment with high level of fibrogenic cytokines that drives epithelial cell dedifferentiation, EMT and tubular atrophy. [9] [10] [11] [12] In many respects, inflammatory infiltration and EMT constitute a vicious circuit of peritubular inflammation, tubular cell dedifferentiation and interstitial fibrosis. 10, 13 However, whether peritubular inflammation and EMT are intrinsically coupled at molecular level is enigmatic.
Tubular EMT is an orchestrated, highly regulated process in which tubular cell dedifferentiation, characterized by loss of the epithelial cell adhesion receptor E-cadherin, is an early event. 14, 15 Using gene expression microarray profiling, we previously identified the inhibitor of differentiation-1 (Id1), a dominant negative antagonist of the basic helixloop-helix (bHLH) transcription factors, 16 as a major trigger for tubular cell dedifferentiation after injury. Id1 expression is rapidly induced in the obstructed kidneys as early as 1 day after unilateral ureteral obstruction (UUO). 17 Ectopic expression of Id1 in tubular epithelial cells represses the expression of E-cadherin and tight-junction protein zonula occludens-1 (ZO-1). Mechanistically, Id1 physically binds to the basic helix-loophelix transcription factor HEB, and sequesters its ability to trans-activate E-cadherin promoter. [16] [17] [18] Id1 protein in the obstructed kidneys is selectively upregulated in the degenerated tubules with a dilated lumen, consistent with its role in mediating tubular epithelial cell dedifferentiation. 17 Somewhat surprisingly, Id1 is predominantly localized in the cytoplasm of the injured kidney epithelial cells in vivo, as demonstrated by an indirect immuofluorescence staining. 17 This seems contradictory to its perceived function as a nuclear transcriptional antagonist that represses E-cahderin and ZO-1 gene expression. This paradox prompted us to further investigate the subcellular localization of Id1 and to explore any unrecognized functions of this protein in the pathogenesis of renal fibrosis.
Here we show that Id1 is present in both the nucleus and cytoplasm of tubular epithelial cells, and it undergoes nucleo-cytoplasmic shuttling. In addition to acting as transcriptional antagonist in the nucleus, cytoplasmic Id1 is able to promote NF-κB signaling and chemokine expression, and facilitate peritubular inflammation. Mice with Id1 deficiency are protected against renal inflammatory infiltration and interstitial fibrosis. Our results establish that Id1, as a single molecule, concomitantly promotes both epithelial cell dedifferentiation and peritubular inflammation, thereby providing an intrinsic, molecular link between two pathogenic events in renal fibrogenesis.
Results

Tubular segment-specific induction of Id1 in fibrotic kidneys
Earlier studies indicate that Id1 is specifically induced in renal tubular epithelia after obstructive injury by immuofluorescence staining. 17 To further identify the tubular segments that express Id1, we carried out double-immunostaining for Id1 and various segmentspecific tubular markers. As shown in Figure 1 , co-localization of Id1 and aquaporin-1 (proximal tubular marker) was clearly evident in the obstructed kidneys at 7 days after unilateral ureteral obstruction (UUO), suggesting a proximal tubule-specific induction of Id1 after kidney injury. Of note, no or little Id1 staining was observed in normal kidneys of the sham-operated mice (data not shown), as previously reported. 17 Interestingly, there was no co-localization of Id1 and Tamm-Horsfall glycoprotein (THP), also known as uromodulin, a marker for the cortical thick ascending limb of the loop of Henle. Similarly, Id1 was not found in the distal convoluted tubules of the obstructed kidneys, as it did not co-localize with thiazide-sensitive NaCl cotransporter (TSC)/NCC, a specific marker for that tubular segment (Figure 1) . Id1, however, was co-stained with renal collecting duct marker, fluorescein-labeled Dolichos Biflorus agglutinin (DBA) (Figure 1 ). Together, it becomes clear that Id1 induction in the fibrotic kidneys takes place in a tubular segment-specific fashion.
Id1 was induced in cultured human proximal tubular epithelial cells (HKC-8) in vitro after incubation with TGF-β1, as previously reported, 17 suggesting that proximal tubular cells in vitro can recapitulate in vivo responses to injury. In view of the in vivo data (Figure 1 ), we also examined whether TGF-β1 regulates Id1 expression in renal collecting duct epithelia as well in vitro. To this end, mouse inner medullary collecting duct epithelial cells (mIMCD-3) were incubated with TGF-β1, and then assessed for Id1 expression. As shown in Supplementary Figure 1 , TGF-β1 induced Id1 mRNA and protein expression in mIMCD-3 cells as well, as demonstrated by real-time RT-PCR and Western blot analyses, respectively.
Id1 undergoes nucleo-cytoplasmic shuttling
Immunostaining revealed that Id1 was localized predominantly in the cytoplasm of renal tubular epithelia after obstructive injury (Figure 1 ). To further clarify this issue, we utilized immunohistochemical staining, an approach with better morphological resolution, to examined Id1 subcellular localization. As shown in Figure 2 , a and b, Id1 was selectively upregulated merely in the degenerated tubules with dilated lumens, but not in the morphologically intact tubules after UUO (Figure 2b ). Higher magnification of the image revealed a clear cytoplasmic and nuclear localization of Id1 protein in the injured tubular epithelium (Figure 2 , arrows in the enlarged box area).
To further address the Id1 subcellular localization, we used a biochemical approach to detect cytoplasmic and nuclear Id1 protein in HKC-8 cells after subcellular fractionation. As shown in Figure 2c , Id1 protein was detectable in both cytoplasm and the nuclei under basal conditions. Upon TGF-β1 stimulation, Id1 was markedly and transiently induced in HKC-8 cells. Notably, the ratio of nuclear versus cytoplasmic Id1 did not substantially change after TGF-β1 treatment. Incubation of HKC-8 cells with leptomycin B, an inhibitor of the nuclear export receptor CRM1 (chromosomal region maintenance 1), 19 also known as exportin 1, resulted in a decrease of Id1 in the cytoplasm, accompanied by a concomitant increase in the nuclei (Figure 2c ), suggesting that the nuclear export receptor CRM1 mediates the cytoplasmic localization of Id1 in tubular epithelial cells.
We also investigated the Id1 subcellular localization by genetically tagging the Id1 with GFP. To this end, an expression vector encoding GFP-Id1 fusion protein was constructed and transiently transfected into HKC-8 cells. Figure 2d showed both cytoplasmic (Figure 2d , arrows) and nuclear (Figure 2d , arrowheads) localization of GFP-Id1. Similarly, incubation with leptomycin B also reduced the cytoplasmic localization of GFP-Id1 fusion protein (Figure 2e ). Collectively, these results indicate that Id1 is localized in both cytoplasm and nuclei, and that there is a dynamic, CRM1-dependent nucleo-cytoplasmic shuttling of Id1 in kidney tubular cells.
Induction of Id1 is closely associated with peritubular inflammation
The cytoplasmic localization of Id1 might imply novel function of this protein, in addition to its role in regulating gene transcription in the nucleus. To address this issue, we first investigated Id1 regulation and its subcellular localization in other models of chronic kidney disease. In an accelerated mouse model of diabetic nephropathy, in which diabetes was induced by streptozotocin (STZ) in the nephrectomized CD-1 mice, 20 Id1 induction was observed specifically in the degenerated, dilated renal tubules at 3 months after STZ injection, whereas morphologically normal tubules were essentially negative for Id1 staining ( Figure 3, a and b) . This unique pattern of Id1 expression is compatible with that in UUO mice (Figure 2b ), suggesting that Id1 induction is associated with tubular cell dedifferentiation and degeneration in this model as well. Of particular interest, there was significant infiltration of inflammatory cells in the close proximity to the Id1-positve tubules (Figure 3b , arrowhead).
To explore the relevance of Id1 induction to the pathogenesis of chronic kidney diseases in humans, we examined the Id1 expression in human kidney biopsies with different nephropathies. As shown in Figure 3c , no or little Id1 staining was observed in human normal kidney. However, substantial induction of Id1 was found in renal tubules of kidney biopsies from patients with various kidney disorders. Notably, Id1 was localized in both cytoplasm and nuclei of tubular cells (Figure 3, d-f, asterisks) . Interestingly, Id1-positive tubules were often surrounded by infiltrated inflammatory cells (Figure 3 , d-f, arrowheads), suggesting that Id1 may not only be instrumental in mediating tubular cell dedifferentiation, but also could potentially play a role in inciting peritubular infiltration of inflammatory cells.
Id1 potentiates NF-κB signaling and promotes RANTES induction in tubular epithelial cells
The close association between Id1 induction and inflammatory infiltration prompted us to investigate whether Id1 modulates renal inflammation and NF-κB signaling. As shown in Figure 4 , a and b, Id1 over-expression enhanced IκBα phosphorylation, an early event of NF-κB signaling that takes place in the cytoplasm, in HKC-8 cells upon TNF-α stimulation. Id1 over-expression also increased p65 NF-κB phosphorylation upon TNF-α stimulation ( Figure 4, c and d) . The magnitude of TNF-α-mediated IκBα and p65 NF-κB phosphorylation were increased in Id1-overexpressing cells. This led to an increased RANTES (regulated on activation, normal T cell expressed), also known as CC-chemokine ligand 5 (CCL5), induction by TNF-α in Id1-over-expressing tubular cells. As shown in Figure 5 , a and b, TNF-α at 0.5 ng/ml induced substantial RANTES expression in the Id1-overexpressing cells, comparing to the pcDNA3 mock-transfected controls. Using chemotaxis assay, we further evaluated the significance of an increased tubular expression of RANTES in recruiting inflammatory cells. To this end, the supernatants of cell cultures were used to assess their ability to attract THP-1 monocyte migration across the Transwell filter. As shown in Figure 5c , conditioned media derived from the Id1-over-expressing cells after TNF-α stimulation were more potent in chemo-attracting THP-1 cells, compared with pcDNA3 controls. Consistently, RANTES was selectively induced in the degenerated tubules in the obstructed kidneys after UUO (Figure 5d ), a pattern similar to Id1 induction in this model (Figure 2b ). Altogether, these results suggest that Id1 sensitizes tubular epithelial cells to produce pro-inflammatory RANTES and facilitates peritubular infiltration of inflammatory cells after injury.
Id1 promotes tubular cell dedifferentiation by inducing Snail1
Over-expression of Id1 leads to tubular cell dedifferentiation characterized by loss of Ecadherin and ZO-1, as previously reported, 17 which is largely mediated by Id1-driven sequestration of transcription factor HEB in the nucleus. To further delineate the mechanism by which Id1 promotes tubular cell dedifferentiation, we examined its potential role in regulating the expression of Snail1, a key transcription factor that is essential for repressing E-cadherin and triggering EMT. 21, 22 As shown in Figure 6a 
Ablation of Id1 reduces renal inflammation after obstructive injury
To determine the role of Id1 in renal inflammation and fibrogenesis in vivo, we employed a knockout mouse model in which Id1 gene is genetically disrupted. Mice with Id1 deficiency (Id1 −/− ) developed normally and displayed no overt abnormality in phenotypes, as previously reported. 24 We first examined the expression of Id1 after obstructive injury in the wild type (Id1 +/+ ) and Id1 null mice (Id1 −/− ). As shown in Figure 7 , a and b, ureteral obstruction induced a significant increase in Id1 mRNA expression in the obstructed kidney of wild-type mice, compared to sham controls. As expected, no Id1 mRNA was detected in the kidneys of Id1 null mice. Id1 deficiency did not significantly affect the induction of Id3, another member of the Id family proteins that shares a high structural similarity to Id1, 16 in the obstructed kidneys after UUO ( Figure 7 , a and c).
To assess the potential effect of Id1 on renal inflammation in vivo, we examined the peritubular infiltration of inflammatory cells including CD3-positive T cells and F4/80-positive monocytes/macrophages in the obstructed kidneys, respectively. As shown in Figure 7d , compared with sham controls, obstructive injury caused substantial T cells and macrophage infiltration in the obstructed kidneys, as illustrated by immunohistochemical staining for CD3 and F4/80 antigens. Id1 deficiency, however, significantly reduced renal infiltration of T cells and macrophages (Figure 7d, arrows) . A computer-aided quantitative analysis also demonstrated a reduction of inflammatory cell infiltration in Id1 null mice after UUO, compared to the wild-type controls ( Figure 7 , e and f).
Id1 deficiency decreases renal expression of inflammatory mediators
We next examined the expression of RANTES, an important inflammatory chemokine in the obstructed kidneys. 25 As shown in Figure 8 , a and b, quantitative, real-time RT-PCR analysis demonstrated a marked induction of RANTES mRNA in the obstructive kidney, when compared with sham controls. However, Id1 deficiency significantly inhibited RANTES mRNA expression. We further investigated the expression of TNF-α, a key inflammatory cytokine that is produced primarily by the infiltrated cells, in the obstructed kidney after UUO. Similarly, Id1 deficiency also reduced TNF-α expression in the obstructed kidneys (Figure 8, a and b) .
We also investigated RANTES protein expression and its localization by immunohistochemical staining. As shown in Figure 8c , no or little RANTES protein was observed in normal, sham-operated kidneys; however, RANTES was induced in the degenerated, dilated renal tubular epithelium in the obstructed kidney at 7 d after UUO. Consistent with the mRNA data, Id1 deficiency also reduced RANTES protein expression in the obstructed kidneys ( Figure 8 , c and d).
Id1 deficiency inhibits myofibroblast activation and matrix expression and reduces renal fibrosis
Finally we assessed the effects of Id1 deficiency on matrix production and renal fibrosis in obstructive nephropathy. To this end, we first examined the effects of Id1 deficiency on the activation of myofibroblasts, the principal matrix-producing cells in fibrotic kidney, after obstructive injury. [26] [27] [28] As shown in Figure 9 , a and b, ureteral obstruction induced a marked increase in the expression of α-SMA, the molecular signature of myofibroblasts. However, Id1 deficiency reduced renal α-SMA expression. Similar results were obtained when using an indirect immunofluorescence staining for α-SMA (data not shown). Figure 9 , c through e, shows the expression of type I and type III collagen mRNA in the obstructed kidneys after UUO. As expected, marked induction of type I and type III collagen mRNA was observed at 7 days after ureteral obstruction in wild-type mice, when compared with their sham controls. However, ablation of Id1 significantly reduced type I and type III collagen mRNA expression ( Figure 9 , c through e). A collagen-specific Picrosirius Red staining also revealed a marked increase in collagen deposition after obstructive injury in wild-type mice, which was reduced in Id1 null mice (Figure 9f ). Quantitative determination of renal hydroxyproline content also confirmed a reduced collagen accumulation in Id1 null mice (Figure 9g ). Together, these results indicate that Id1 deficiency inhibits myofibroblast activation, attenuates matrix production and mitigates renal fibrosis in obstructive nephropathy.
Discussion
The linkage between inflammation and renal fibrosis has long been established, [29] [30] [31] and is also consistent with pathohistological evidence, as fibrotic foci in the injured kidneys are typically instigated and encircled by inflammatory infiltrates. The classical view on the connection of inflammation/fibrosis is thought to be mediated by a paracrine fashion, in which inflammatory cells secrete profibrotic cytokines that act on resident fibroblasts and tubular cells to promote fibrogenesis. 32, 33 In this study, we demonstrate an intrinsic connection between inflammatory signal and EMT within the same tubular cells at molecular levels. Id1 is selectively up-regulated in the degenerated proximal tubules and collecting ducts, and is present in both cytoplasm and nucleus. While nuclear Id1 promotes tubular cell dedifferentiation by transcriptionally repressing E-cadherin and ZO-1 expression, 17 cytoplasmic Id1 potentiates NF-κB signaling and pro-inflammatory RANTES expression, and facilitates peritubular infiltration of inflammatory cells. These studies have clearly established that Id1, as a single molecule, intrinsically couples inflammation and tubular dedifferentiation, two important pathogenic events in renal fibrogenesis.
Id1 is the prototype of a family of transcriptional antagonists consisting of four members (Id1 through Id4), each of them with distinct expression pattern. 16 Both Id1 and Id3 are induced in the fibrotic kidneys after obstructive injury, and genetic ablation of Id1 does not substantially affect Id3 induction in mice ( Figure 6 ). We previously identified Id1 as an important player in mediating cell dedifferentiation of renal tubular epithelium, the early event of tubular EMT in the fibrotic kidneys. 17 Because Id1 lacks the basic DNA binding domain but retains the ability to interact with HEB, such an Id1/HEB heterodimeric complex formation sequesters the ability of HEB to bind to the E-boxes in the E-cadherin gene promoter. 17 In such way, Id1 acts as a dominant-negative inhibitor and blocks the HEBmediated E-cadherin and ZO-1 expression, leading to epithelial cell dedifferentiation. 17 This assumption is consistent with and supported by the characteristic pattern of Id1 induction, in which Id1 is exclusively upregulated in the degenerated tubules with a dilated lumen in various kinds of nephropathies in mice and humans (Figures 2 and 3) . Of interest, the present study further reveals that Id1 is also able to induce the expression of Snail1 ( Figure  6 ), a master transcription factor that not only suppresses E-cadherin but also induces the expression of mesenchymal genes. 21, 23, 34 Furthermore, Id1 and Snail1 mutually induce each other (Figure 6 ), leading to the formation of a positive feedback loop. Taken together, these results indicate that Id1, as its name implied, triggers tubular epithelial cell dedifferentiation by specifically repressing E-cadherin via binding to and sequestration of HEB and inducing Snail1 expression (Figure 6f ), which apparently takes place in the nucleus of tubular epithelial cells. Subcellular distribution of Id1 protein, however, appears inconsistent with its perceived function as a transcriptional antagonist, because it is largely localized in the cytoplasm of renal tubular epithelium in vivo. The cytoplasmic localization of Id1 is confirmed by multiple approaches, including immunohistochemical staining, cellular fractionation, and direct visualization of GFP-tagged Id1 fusion protein. Therefore, it is highly unlikely that this pattern of Id1 subcellular distribution is caused by technical shortcomings such as nonspecific staining. Furthermore, treatment with the nuclear export inhibitor leptomycin B reveals a nuclear retention of Id1, suggesting a CRM1/exportin-dependent nuclear export of Id1 at work in tubular cells (Figure 2) . Such a nucleo-cytoplasmic shuttling of Id1 is also observed in human umbilical vein endothelial cells when cultured on Matrigel, and it is regulated by protein kinase A. 35 Whether, and how, this nucleo-cytoplasmic shuttling of Id1 in tubular epithelial cells is regulated remain to be elucidated; nevertheless, it might not be controlled by TGF-β1, as the ratio of nuclear/cytoplasmic Id1 remains constant after TGF-β1 incubation in HKC-8 cells, despite an elevated level of total cellular Id1 in this setting.
One of the novel findings in this study is the identification of Id1 as an important regulator of peritubular inflammation after renal injury. This notion is substantiate by several lines of evidences. First, there is a close proximity between inflammatory infiltrates and the Id1-positive tubules in the diseased kidneys (Figure 3 ). More importantly, ectopic expression of Id1 potentiates IκBα phopshorylation and p65 NF-κB activation in tubular cells, and promotes RANTES expression after TNF-α stimulation. Consistently, conditioned media derived from Id1-overexpressing cells facilitate the recruitment and infiltration of inflammatory cells in chemotaxis assay (Figure 5c ). Furthermore, genetic ablation of Id1 protects the kidneys against inflammatory infiltration of T cells and macrophages after obstructive injury (Figure 7 ). It should be noted that previous studies have shown that Id1 promotes cell survival in prostate cancer and breast cancer cells, and induces the proliferation of cochlear sensory epithelial cells via NF-κB activation. [36] [37] [38] Id1 is also reported to potentiate NF-κB activation in a T cell line, leading to overproduction of cytokines such as TNF-α. 39 These studies further strengthen the intrinsic connection between Id1 and NF-κB activation, although the molecular details remain to be elucidated. Of note, because IκBα phosphorylation is an early event in NF-κB signaling that takes place in the cytoplasm, this implies that the promotion of NF-κB signaling is operated presumably by cytoplasmic Id1. Along this line, it becomes clear that Id1 possesses two distinct functions, dependent on its subcellular localization. While nuclear Id1 induces tubular cell dedifferentiation by repressing E-cadherin expression via sequestering HEB and inducing Snail1, cytoplasmic Id1 is able to promote renal inflammation by potentiating NF-κB signaling and chemokine expression. Therefore, Id1, acting on distinct signal pathways in different subcellular compartments, intrinsically couples tubular cell dedifferentiation and peritubular inflammation (Figure 6f ).
Renal fibrogenesis usually instigates focally in the proximity of microvasculature, an inflammatory and fibrotic microenvironment, before progressing into widespread tissue fibrosis. What constitutes the molecular basis of this fibrotic niche is poorly understood. Our studies suggest that Id1 is well suited to serve as a major and integral element of the fibrotic niche in diseased kidneys after injury. Id1 is induced rapidly and selectively in the degenerated tubules, and it intrinsically connects tubular cell dedifferentiation and peritubular inflammation. Therefore, Id1 is instrumental in creating a focal, inflammatory and fibrotic microenvironment, which further drives fibrogenic responses. As illustrated in Id1 null mice, targeting Id1 could be beneficial in preserving tubular cell integrity, reducing peritubular inflammation and ameliorating renal fibrogenesis.
Materials and Methods
Cell culture and treatment
Human proximal tubular epithelial cell line (clone-8) (HKC-8) was provided by Dr. L. Racusen of Johns Hopkins University. Mouse inner medullary collecting duct epithelial cells (mIMCD-3) were obtained from American Type Culture Collection (ATCC; Manassas, VA). 40 Cells were cultured in Dulbecco's modified Eagle's medium (DMEM)-Ham's F12 medium supplemented with 10% fetal bovine serum (FBS). HKC-8 cells were seeded at ~ 70% confluence in complete medium containing 10% FBS. Twenty four hours later, the cells were changed to serum-free medium and incubated for 16 h. Cells were then treated with recombinant human TNF-α (R & D Systems, Minneapolis, MN) for various periods of time at the concentration of 5 ng per ml except otherwise indicated. The cells were then collected at different time points for Western blot analysis. Serum-starved mIMCD-3 cells were treated with TGF-β1 (2 ng/ml) for various periods of time as indicated, and then collected for real-time RT-PCR and Western blot analyses. For some studies, cells were transfected with Id1 expression vector (pCMV-Id1), GFP-tagged Id1 expression vector (pGFP-Id1) or Snail1 expression vector (pHA-Snail1) by using Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA). Id1 expression vector (pCMV-Id1) was described previously. 17 Construction of the GFP-tagged Id1 expression vector (pGFP-Id1) was carried out by standard molecular cloning techniques, and its correct sequences were confirmed by DNA sequencing at the University of Pittsburgh Biomedical Research Support Facilities.
Cellular fractionation
For preparation of nuclear protein, HKC-8 cells were washed twice with cold phosphatebuffered saline (PBS) and scraped off the plate with a rubber policeman. After centrifugation, cell pellets were resuspended in Buffer A (10 mM HEPES pH 7.9, 1.5 mM MgCl2, 10 nM KCl, 0.5% NP-40 and 1% protease inhibitor cocktail (Sigma)) and lysed with homogenizer. Cell nuclei were collected by centrifugation at 5,000 rpm for 15 min, and the supernatants were saved as cytoplasmic preparation. After washing with Buffer B (10 mM HEPES pH 7.9, 1.5 mM MgCl 2 , 10 nM KCl and 1% protease inhibitor cocktail), nuclei were lysed in SDS sample buffer. 41 
Animal model
Colonies of homozygous Id1 knockout (Id1 −/− ) and wild-type (Id1 +/+ ) mice were described previously. 24 A routine PCR protocol was used for genotyping of tail DNA samples with following primers: 5′-TCCTGCAGCATGTAATCGAC-3′, 5′-GACGTGCTACTTCCATTTGTCA-3′ and 5′-GAGACCCACTGGAAAGGACA-3′, which yielded 344 and 540-bp bands for the wild-type and mutated alleles, respectively. The experiments were performed on male Id1 −/− and Id1 +/+ mice with identical genetic backgrounds and with an average age of 8 weeks. There was no statistical difference in the body weight of Id1 −/− and Id1 +/+ mice at the time of the experiments. Unilateral ureteral obstruction (UUO) was performed using an established procedure, as described elsewhere. 42 Mice were sacrificed at day 7 after surgery and kidneys were removed. One part of the kidney was fixed in 10% phosphate-buffered formalin, followed by paraffin embedding for histologic and immunohistochemical studies. Another part was immediately frozen in Tissue-Tek OCT compound (Sakura Finetek, Torrance, CA) for cryosection. The remaining kidneys were snap-frozen in liquid nitrogen and stored at −80°C for extraction of RNA and protein. All animal studies were approved by the Institutional Animal Care and Use Committee at the University of Pittsburgh.
Human tissue samples
Human kidney specimens were obtained from diagnostic renal biopsy performed at the University of Pittsburgh Medical Center. As normal controls, non-tumor kidney tissue from the patients who had renal cell carcinoma and underwent nephrectomy was used. Studies involving human tissues were approved by the Institutional Review Board at the University of Pittsburgh.
Western blot analysis
Western blot analysis for specific protein expression was performed essentially according to an established procedure. 17 The primary antibodies used were as follows: anti-RANTES (sc-1410), anti-Id1 (sc-488) and anti-actin (sc-1616) (Santa Cruz Biotechnology, Santa Cruz, CA), anti-phospho-IκBα (Ser32/36), anti-phospho-p65 NF-κB (Ser536), anti-p65 NF-κB (Cell Signaling Technology, Beverly, MA), anti-Snail1 (ab17732), anti-histone H3 (Abcam, Cambridge, MA), anti-E-cadherin (#610182; BD Transduction, San Jose, CA) anti-α-SMA (clone 1A4), anti-α-tubulin (T9026) (Sigma, St. Louis, MO), anti-GAPDH (Ambion, Austin, TX). Quantification was performed by measuring the intensity of the signals with the use of NIH Image analysis software.
Quantitative, real-time reverse transcriptase (RT)-PCR analysis
Total RNA was extracted using TRIzol RNA isolation system (Invitrogen). The first strand of cDNA was synthesized using 2 μg of RNA in 20 μl of reaction buffer by reverse transcription using AMV-RT (Promega, Madison, WI) and random primers at 42°C for 30 min. Quantitative, real-time RT-PCR was performed on ABI PRISM 7000 Sequence Detection System (Applied Biosystems, Foster City, CA), as described previously. 22 The PCR reaction mixture in a 25-μl volume contained 12.5 μl 2x SYBR Green PCR Master Mix (Applied Biosystems), 5 μl diluted RT product (1:10) and 0.5 μM sense and antisense primer sets. The sequences of the primer pairs were given in Supplementary Table 1. PCR reaction was run by using standard conditions. The mRNA levels of various genes were calculated after normalizing with β-actin. Some PCR products were also size fractionated on a 1.0% agarose gel and detected by ethidium bromide staining.
Immunofluorescence staining
Indirect immunofluorescence staining was performed using an established procedure. 17, 43 Briefly, kidney cryosections were fixed with cold methanol:acetone (1:1) for 10 min at −20°C. Following blocking with 20% normal donkey serum in PBS buffer, the slides were incubated with the primary antibodies against Id1 (sc-488), aquaporin-1 (sc-9878), TammHorsfall glycoprotein (THP) (sc-19554) (Santa Cruz Biotechnology, Santa Cruz, CA), thiazide-sensitive NaCl cotransporter (TSC)/NCC (AB3553; Millipore, Billerica, MA), and fluorescein-labeled Dolichos Biflorus agglutinin (DBA) (FL-1031; Vector Lab, Burlingame, CA). To visualize the primary antibodies, slides were stained with cyanine Cy2-or Cy3-conjugated secondary antibodies (Jackson ImmunoResearch Laboratories, West Grove, PA). Stained slides were viewed with a Nikon Eclipse E600 Epi-fluorescence microscope equipped with a digital camera (Melville, NY).
Histology and immunohistochemical staining
Kidney sections were prepared at 4 μm thickness by a routine procedure. Sections were stained with hematoxylin-eosin, periodic acid-Schiff, and Picrosirius Red reagents by standard protocol. 5 Immunohistochemical staining of kidney sections was performed by an established protocol. 4, 5 In brief, paraffin-embedded sections were stained with anti-Id1 (sc-488), anti-CD3 (sc-20047) (Santa Cruz Biotechnology), anti-F4/80 (14-4801-82; eBioscience, San Diego, CA), and anti-RANTES (500-P118; PeproTech Inc., Rocky Hill, NJ) antibodies using the M.O.M. immunodetection kit, according to the protocol specified by the manufacturer (Vector Laboratories, Burlingame, CA). Slides were viewed with an Eclipse E600 microscope equipped with a digital camera (Nikon, Melville, NY). CD-3, F4/80, and RANTES staining were semi-quantified by a computer-aided morphometric analysis (MetaMorph; Universal Imaging Co., Downingtown, PA). Briefly, a grid containing 117 (13 × 9) sampling points was superimposed onto images of cortical high-power field (x400). The number of grid points overlying positive area (except tubular lumen and glomeruli) was counted and expressed as a percentage of all sampling points. For each kidney, 5 randomly selected, non-overlapping fields were analyzed in a blinded manner.
Chemotaxis assay
Chemotaxis assay was performed using a 24-well Transwell plate as described previously. 5 Human monocytic cell line (THP-1) (American Type Culture Collection, Manassas, VA) was maintained in RPMI-1640 medium supplemented with 10% fetal calf serum. Cultured THP-1 cells (5×10 5 in 100 μl) were added onto the upper chamber of the Transwell insert (5 μm polycarbonate filter, Corning Inc. Corning, NY). Id1-overexpressing cell conditioned media (0.5 ml) were added in the lower chamber of the Transwell. After incubation at 37°C for 4 h, the number of cells migrated to the lower chamber of the Transwell was counted. Data are expressed as percentage of the migrated cells in total number of input cells.
Quantitative determination of tissue hydroxyproline content
To quantitative measurement of collagen deposition in the kidney, total tissue collagen was estimated by biochemical analysis of the hydroxyproline in the hydrolysates extracted from kidney samples. This assay is based on the observation that essentially all the hydroxyproline in animal tissues is found in collagen. Briefly, kidney samples were dried at 110°C for 48 h, and then accurately weighed. Dry kidney was hydrolyzed in sealed, oxygenpurged glass ampoules containing 2 ml of 6 N HCl at 110°C for 24 h. Hydroxyproline content in the hydrolysates was chemically quantified according to the techniques previously described. 12 Tissue hydroxyproline content was expressed as μg per mg dry kidney weight.
Statistical Analyses
All data examined were expressed as mean ± SEM. Statistical analyses of the data were performed using SigmaStat software (Jandel Scientific Software, San Rafael CA). Comparison between groups was made using one-way ANOVA, followed by StudentNewman-Keuls test. P < 0.05 was considered significant. collagen content was estimated by measuring hydroxyproline levels in obstructed kidneys at days after UUO. Hydroxyproline levels were expressed as μg/mg dry kidney weight. *P < 0.05 (n = 6).
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